Inability to swallow or absorb oral medication

Uncontrolled medical disorder or infection

Use of CYP3A4 inhibitors/inducers or drugs with risk of Torsades de Pointes

Uncontrolled or Significant cardiovascular disease

Any significant bleeding disorder

Female subjects of childbearing potential

Male subjects unwilling to use an effective method of contraception throughout the conduct of the study and for 2 months thereafter

A Study of Dasatinib to See How Liver Impaired and Healthy Subjects Process and React to the Study Drug